264P An open-label, uncontrolled study of magrolimab (ONO-7913) and nivolumab (ONO-4538) in combination with standard modified-FOLFIRINOX chemotherapy as first-line treatment in patients with metastatic pancreatic cancer
Title:
264P An open-label, uncontrolled study of magrolimab (ONO-7913) and nivolumab (ONO-4538) in combination with standard modified-FOLFIRINOX chemotherapy as first-line treatment in patients with metastatic pancreatic cancer
Author:
Ueno, M. Imaoka, H. Isayama, H. Murohisa, G. Kitano, S. Ishigaki, K. Mizutani, T. Hamamoto, Y. Yano, M. Morizane, C.